Home -> Law Blog Directory -> Corporate & Securities Law Blogs -> Representing Investors
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate & Securities Law
: Representing InvestorsFabrice Tourre And The Lawsuit Against Goldman Sachs
By Keith Griffin
A recent lawsuit against Fabrice Tourre may be emblematic of public sentiment regarding Wall Street. The Securities and Exchange Commission (SEC) filed a civil lawsuit against Tourre and his employer, Goldman Sachs, on April 16, accusing the duo of defrauding investors by misstating and omitting key facts about a financial product tied to mortgage-related investments.
The focus of the lawsuit is on a collateralized debt obligation that Tourre created. The performance of that CDO, called Abacus, was linked to the performance of the housing market. When the housing market tanked, so, too, did Abacus. The SEC isn?t focused on that aspect, however. Its lawsuit concerns a hedge fund, Paulson & Co., which selected the losing assets that went into Abacus and then bet against them. Goldman never revealed Paulson?s role to investors, according to the SEC.
Meanwhile, another company became involved in the deal - ACA Management. Allegedly, Goldman and Tourre convinced ACA that Paulson was investing in Abacus, instead of betting against it.
The SEC?s complaint accuses Tourre as the person principally responsible for ABACUS 2007-AC1. Tourre structured the transaction, prepared the marketing materials, and communicated directly with investors, the SEC says. Tourre also allegedly knew of Paulson & Co.’s undisclosed short interest and role in the collateral selection process.
In addition, Tourre is charged with misleading ACA into believing that Paulson & Co. invested approximately $200 million in the equity of ABACUS, indicating that Paulson & Co.?s interests in the collateral selection process were closely aligned with the interests of ACA. In reality, however, their interests were sharply conflicting.
In the end, Paulson paid Goldman $15 million for putting Abacus together. Investors lost more than $1 billion, while Paulson made a profit of $1 billion, the SEC says.
Full post as published by Representing Investors on April 19, 2010 (boomark / email).
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Copyright Lawsuits: Critical Issues Before Filing Copyright
Federa Rule 11(b) Considerations
Vioxx Lawsuits
Vioxx personal injury suits are a seroius concern for Merck and patietns
Construction Site Accidents
Lawsuits related to accidents
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Bausch Lomb Renu Moistureloc Linked to Eye Infection Fusarium Keratiti
Contact Lens Solution Product Recall
Goldman Sachs Agrees $550 Million Civil Suit Settlement
$550 Million Fine Against Goldman Sachs
Female Employees Sue Goldman Sachs for Sex Discrimination
Female Employees Sue Goldman Sachs for Sex Discrimination
Goldman Sachs Faces Fraud Charges
Goldman Sachs Faces Fraud Charges
The Goldman Sachs Group, Inc.
401k / ERISA Stock Fraud
Goldman Sachs
Agrees $60 Million Subprime Settlement in Massachusetts
Couple Awarded Nearly One Million Dollars in Lawsuit
Condo Lawsuit Gets $1 Million Award

Questions Surrounding the SECs Litigation vs Goldman
Goldman Sachs & Cumberland Strategy Change
Rep. Marcy Kaptur Cross-Examines Henry Paulson About Warren Buffet-Goldman Sachs Deal
Paulson Puts Goldman Sachs Crony in Charge
More on David Viniar's Statment Regarding Goldman Sachs v. Sergey Aleynikov








